In October 2019, Gryt Health acquired ownership of Vivibot, our mental health, interactive chatbot designed to help cancer survivors learn practical coping skills and hear stories from other survivors after treatment. Here’s the press release making the announcement.
In May 2021, Gryt Health announced our collaboration to improve bone health education publication being published in the Cancer Management and Research journal.
In March 2018, GRYT Health and Bristol-Myers Squibb Company (NYSE: BMY) announced a strategic pilot utilizing de-identified data to integrate patient insights and clinical research with the goal of building a foundation of real-world data that will support improved clinical trial design, disease management and the overall well-being of patients living with cancer.
A press release from #GVCC21. See what you missed and see the link at the bottom to pre-register for #GVCC22!
May 12, 2020, Rochester, NY & Princeton, NJ – In light of the COVID-19 pandemic, GRYT Health (“grit”), a digital health company with a social purpose and creator of the Global Virtual Cancer Conference and the GRYT Health platform, and Bristol Myers Squibb (NYSE: BMY) have partnered to develop the COVID Advocacy Exchange, a virtual platform to unite patient advocacy organizations, patients, policy makers, healthcare practitioners and industry in the exchange of information.
January 2021 Press Release about our 2-year BEACON Bone Health Education Needs Assessment Study that was done with more than 250 cancer patients. We hosted a virtual event to share the findings of the result.
November 2020 press release for the wrap-up of GVCC 20. The Global Virtual Cancer Conference is an annual, cornerstone event of Gryt Health. Links included for pre-registration and the call for speakers for GVCC22!
March 2020 Press Release announcing Gryt Health’s partnership with the American Association of Precision Medicine (AAPM) to bring timely ongoing updates, expertise, resources and connection to those with a cancer diagnosis.
